The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
Open accessAbstract
BACKGROUND: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable blood test based on platelet and lymphocyte counts has been associated with poor prognosis in patients with different types of cancer. The present study was aimed to investigate the prognostic significance of the preoperative PLR in a large cohort of breast cancer patients. METHODS: Data from 793 consecutive non-metastatic breast cancer patients, treated between 1999 and 2004, were evaluated retrospectively. The optimal cutoff values for the PLR were calculated using receiver operating curve analysis. Cancer-specific survival (CSS), overall survival (OS) as well as distant metastasis-free survival (DMFS) were assessed using the Kaplan-Meier method. To evaluate the independent prognostic significance of PLR, multivariable Cox regression models were applied for all three different end points. RESULTS: Univariable analysis revealed a significant association between the elevated preoperative PLR and CSS (hazard ratio (HR): 2.75, 95% confidence interval (CI): 1.57-4.83, P<0.001) that remained statistically significant in multivariable analysis (HR: 2.03, 95% CI: 1.03-4.02, P=0.042). An increased PLR was also significantly associated with decreased OS in univariable (HR: 2.45, 95% CI: 1.43-4.20, P=0.001) and in multivariable analysis (HR: 1.92, 95% CI: 1.01-3.67, P=0.047). Furthermore, univariable analysis showed a significant impact of increased PLR on DMFS (HR: 2.02, 95% CI: 1.18-3.44, P=0.010). Subgroup analysis revealed significant associations of the elevated PLR on the primary end point CSS for all breast cancer subtypes. This association retained its significance in multivariable analysis in patients with luminal B tumours (HR: 2.538, 95% CI: 1.043-6.177, P=0.040). CONCLUSIONS: In this study, we identified the preoperative PLR as an independent prognostic marker for survival in breast cancer patients. Independent validation of our findings is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Albain, K. S., Barlow, W. E., Shak, S., Hortobagyi, G. N., Livingston, R. B., Yeh, I.-T., Ravdin, P., Bugarini, R., Baehner, F. L., Davidson, N. E., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70314-6 · Cited by 1,407
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Ray-Coquard, I., Cropet, C., Van Glabbeke, M., Sebban, C., Le Cesne, A., Judson, I., Tredan, O., Verweij, J., Biron, P., Labidi, I., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3845 · Cited by 784
Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., Fletcher, C. D., O’Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.028 · Cited by 757
Pierce, B. L., Ballard-Barbash, R., Bernstein, L., Baumgartner, R. N., Neuhouser, M. L., Wener, M. H., Baumgartner, K. B., Gilliland, F. D., Sorensen, B. E., McTiernan, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9068 · Cited by 691
Review: Role of Blood Platelets in Infection and Inflammation
Klinger, M. H. F., & Jelkmann, W. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260286623 · Cited by 505
Dieci, M. V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M. C., Delaloge, S., Curigliano, G., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt556 · Cited by 460
Smith, R. A., Bosonnet, L., Raraty, M., Sutton, R., Neoptolemos, J. P., Campbell, F., & Ghaneh, P. (2009) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.12.057 · Cited by 458
Kwon, H.-C., Kim, S. H., Oh, S. Y., Lee, S., Lee, J. H., Choi, H.-J., Park, K.-J., Roh, M. S., Kim, S.-G., Kim, H.-J., et al. (2012) · Biomarkers · doi:10.3109/1354750x.2012.656705 · Cited by 409
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
Ropponen, K. M., Eskelinen, M. J., Lipponen, P. K., Alhava, E., & Kosma, V.-M. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199707)182:3<318::aid-path862>3.0.co;2-6 · Cited by 398
The role of intratumoral and systemic IL-6 in breast cancer
Dethlefsen, C., Højfeldt, G., & Hojman, P. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2488-z · Cited by 363
West, N. R., Milne, K., Truong, P. T., Macpherson, N., Nelson, B. H., & Watson, P. H. (2011) · Breast Cancer Research · doi:10.1186/bcr3072 · Cited by 356
Bachelot, T., Ray-Coquard, I., Menetrier-Caux, C., Rastkha, M., Duc, A., & Blay, J.-Y. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600956 · Cited by 317
Seo, A. N., Lee, H. J., Kim, E. J., Kim, H. J., Jang, M. H., Lee, H. E., Kim, Y. J., Kim, J. H., & Park, S. Y. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.634 · Cited by 317
Stotz, M., Pichler, M., Absenger, G., Szkandera, J., Arminger, F., Schaberl-Moser, R., Samonigg, H., Stojakovic, T., & Gerger, A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.785 · Cited by 310
Self-citationLeitch, E. F., Chakrabarti, M., Crozier, J. E. M., McKee, R. F., Anderson, J. H., Horgan, P. G., & McMillan, D. C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604027 · Cited by 307
Lee, S., Oh, S. Y., Kim, S. H., Lee, J. H., Kim, M. C., Kim, K. H., & Kim, H.-J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-350 · Cited by 281
Decreased Total Lymphocyte Counts in Pancreatic Cancer: An Index of Adverse Outcome
Fogar, P., Sperti, C., Basso, D., Sanzari, M. C., Greco, E., Davoli, C., Navaglia, F., Zambon, C.-F., Pasquali, C., Venza, E., et al. (2006) · Pancreas · doi:10.1097/01.mpa.0000188305.90290.50 · Cited by 260
Azab, B., Shah, N., Radbel, J., Tan, P., Bhatt, V., Vonfrolio, S., Habeshy, A., Picon, A., & Bloom, S. (2013) · Medical Oncology · doi:10.1007/s12032-012-0432-4 · Cited by 249
Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
Raungkaewmanee, S., Tangjitgamol, S., Manusirivithaya, S., Srijaipracharoen, S., & Thavaramara, T. (2012) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2012.23.4.265 · Cited by 246
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
Asher, V., Lee, J., Innamaa, A., & Bali, A. (2011) · Clinical and Translational Oncology · doi:10.1007/s12094-011-0687-9 · Cited by 238
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
Drukker, C. A., Bueno‐de‐Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Roumen, R. M. H., Knauer, M., van 't Veer, L. J., Sonke, G. S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28082 · Cited by 227
Absenger, G., Szkandera, J., Pichler, M., Stotz, M., Arminger, F., Weissmueller, M., Schaberl-Moser, R., Samonigg, H., Stojakovic, T., & Gerger, A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.346 · Cited by 225
Self-citationAlexandrakis, M. G., Passam, F. H., Moschandrea, I. A., Christophoridou, A. V., Pappa, C. A., Coulocheri, S. A., & Kyriakou, D. S. (2003) · American Journal of Clinical Oncology · doi:10.1097/00000421-200304000-00007 · Cited by 198
Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape
Salazar-Onfray, F., López, M. N., & Mendoza-Naranjo, A. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.015 · Cited by 194
Serum Interleukin 6, Plasma VEGF, Serum VEGF, and VEGF Platelet Load in Breast Cancer Patients
Benoy, I., Salgado, R., Colpaert, C., Weytjens, R., Vermeulen, P. B., & Dirix, L. Y. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.n.008 · Cited by 188
He, W., Yin, C., Guo, G., Jiang, C., Wang, F., Qiu, H., Chen, X., Rong, R., Zhang, B., & Xia, L. (2013) · Medical Oncology · doi:10.1007/s12032-012-0439-x · Cited by 187
Egan, K., Crowley, D., Smyth, P., O'Toole, S., Spillane, C., Martin, C., Gallagher, M., Canney, A., Norris, L., Conlon, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026125 · Cited by 181
Roxburgh, C. S. D., & McMillan, D. C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.09.001 · Cited by 175
Carruthers, R., Tho, L. M., Brown, J., Kakumanu, S., McCartney, E., & McDonald, A. C. (2012) · Colorectal Disease · doi:10.1111/j.1463-1318.2012.03147.x · Cited by 152
Mohammed, Z. M. A., Going, J. J., Edwards, J., Elsberger, B., Doughty, J., & McMillan, D. C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.347 · Cited by 148
Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma.
Lee, Y.-Y., Choi, C. H., Kim, H.-J., Kim, T.-J., Lee, J., Lee, J., Bae, D., & Kim, B. (2012) · PubMed · Cited by 146
Smith, R. A., Ghaneh, P., Sutton, R., Raraty, M. G. T., Campbell, F., & Neoptolemos, J. P. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0554-3 · Cited by 142
Koch, A., Fohlin, H., & Sörenson, S. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31819578c8 · Cited by 104
Raney, R. B., Crist, W., Maurer, H. M., & Foulkes, M. A. (2006) · Cancer · doi:10.1002/1097-0142(19830701)52:1<126::aid-cncr2820520123>3.0.co;2-y · Cited by 95
Suzuki, K., Aiura, K., Ueda, M., & Kitajima, M. (2004) · Pancreas · doi:10.1097/00006676-200408000-00008 · Cited by 86
Ege, H., Gertz, M. A., Markovic, S. N., Lacy, M. Q., Dispenzieri, A. A., Hayman, S. R., Kumar, S. K., & Porrata, L. F. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07123.x · Cited by 77
Kono, S. A., Heasley, L. E., Doebele, R. C., & Camidge, D. R. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912799095144 · Cited by 64
Saghatchian, M., Mook, S., Pruneri, G., Viale, G., Glas, A. M., Guerin, S., Cardoso, F., Piccart, M. J., Tursz, T., Delaloge, S., et al. (2013) · The Breast · doi:10.1016/j.breast.2012.12.002 · Cited by 50
Seretis, C., Seretis, F., Lagoudianakis, E., Politou, M., Gemenetzis, G., & Salemis, N. S. (2012) · International Journal of Surgical Oncology · doi:10.1155/2012/653608 · Cited by 32
Individual risk profiling for breast cancer recurrence: towards tailored follow-up schemes
Kraeima, J., Siesling, S., Vliegen, I. M. H., Klaase, J. M., & IJzerman, M. J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.401 · Cited by 16
Cited by
Tumour-associated neutrophils in patients with cancer
Shaul, M. E., & Fridlender, Z. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0222-4 · Cited by 1,023
Neutrophils in Cancer: Two Sides of the Same Coin
Uribe-Querol, E., & Rosales, C. (2015) · Journal of Immunology Research · doi:10.1155/2015/983698 · Cited by 422
Balta, S., & Ozturk, C. (2015) · Platelets · doi:10.3109/09537104.2014.979340 · Cited by 358
The neutrophil-to-lymphocyte ratio: a narrative review
Socorro Faria, S., Fernandes Jr, P. C., Barbosa Silva, M. J., Lima, V. C., Fontes, W., Freitas-Junior, R., Eterovic, A. K., & Forget, P. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.702 · Cited by 332
Koh, C.-H., Bhoo-Pathy, N., Ng, K.-L., Jabir, R. S., Tan, G.-H., See, M.-H., Jamaris, S., & Taib, N. A. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.183 · Cited by 327
Metadata
- Authors
- Krenn-Pilko, S., Langsenlehner, U., Thurner, E.-M., Stojakovic, T., Pichler, M., Gerger, A., Kapp, K. S., & Langsenlehner, T.
- Venue
- British Journal of Cancer
- Published
- 2014-03-27
- Volume
- 110
- Issue
- 10
- Pages
- 2524-2530
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1982453726
- Cited by
- 281
- References
- 47
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.